Healthcare Realty Trust Inc HR
We take great care to ensure that the data presented and summarized in this overview for HEALTHCARE REALTY TRUST INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding HR
View all-
Redpoint Investment Management Pty LTD35.4KShares$621,9010.11% of portfolio
-
Bartlett & Co. LLC1KShares$17,5500.0% of portfolio
-
Private Capital Group, LLC319Shares$5,5980.01% of portfolio
-
Fieldpoint Private Securities, LLC77Shares$1,3510.0% of portfolio
-
Exane Derivatives3Shares$520.0% of portfolio
-
Retirement Group, LLC1Shares$170.0% of portfolio
-
Huntington National Bank Columbus, OH1Shares$170.0% of portfolio
Latest Institutional Activity in HR
Top Purchases
Top Sells
About HR
Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of September 30, 2020, the Company owned 211 real estate properties in 24 states totaling 15.5 million square feet and was valued at approximately $5.5 billion. The Company provided leasing and property management services to 11.9 million square feet nationwide.
Insider Transactions at HR
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 20
2022
|
Christann M Vasquez Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
28,535
-100.0%
|
-
|
|
Jul 20
2022
|
John Knox Singleton Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
19,082
-100.0%
|
-
|
|
Jul 20
2022
|
John Knox Singleton Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
38,197
-100.0%
|
-
|
|
Jul 20
2022
|
Julie F. Wilson EVP - Operations |
SELL
Sale (or disposition) back to the issuer
|
Direct |
93,085
-100.0%
|
-
|
|
Jul 20
2022
|
James Joseph Iv Kilroy Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,921
-100.0%
|
-
|
|
Jul 20
2022
|
Todd J Meredith President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
585,264
-100.0%
|
-
|
|
Jul 20
2022
|
Peter F Sr Lyle Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
6,652
-100.0%
|
-
|
|
Jul 20
2022
|
Peter F Sr Lyle Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,296
-100.0%
|
-
|
|
Jul 20
2022
|
Robert E Hull EVP - Investments |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
48
-100.0%
|
-
|
|
Jul 20
2022
|
Robert E Hull EVP - Investments |
SELL
Sale (or disposition) back to the issuer
|
Direct |
185,739
-100.0%
|
-
|
|
Jul 20
2022
|
Ajay Gupta Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,509
-100.0%
|
-
|
|
Jul 20
2022
|
J Christopher Douglas Executive VP & CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
229,505
-100.0%
|
-
|
|
Jul 20
2022
|
Amanda L Callaway SVP & Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
85,184
-100.0%
|
-
|
|
Jul 20
2022
|
Edward Hall Braman Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
24,285
-100.0%
|
-
|
|
Jul 20
2022
|
John M Bryant Jr Executive Vice President & GC |
SELL
Sale (or disposition) back to the issuer
|
Direct |
208,573
-100.0%
|
-
|
|
Jul 20
2022
|
John V Abbott Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,161
-100.0%
|
-
|
|
Jul 20
2022
|
Nancy H Agee Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
31,789
-100.0%
|
-
|
|
Jul 20
2022
|
Nancy H Agee Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
3,431
-100.0%
|
-
|
|
May 13
2022
|
Nancy H Agee Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,355
+9.55%
|
$97,295
$29.8 P/Share
|
|
May 13
2022
|
Christann M Vasquez Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,355
+10.52%
|
$97,295
$29.8 P/Share
|